42143-23-7

Basic information

• Product Name: QUINOLINE-5,6-DIAMINE
• Synonyms: 5,6-QUINOLINEDIAMINE;5,6-DIAMINOQUINOLINE;AKOS BBS-00000169;IFLAB-BB F1244-0007;QUINOLINE-5,6-DIAMINE;OTAVA-BB BB7216640667;5,6-Diaminoquinoline, 5,6-Diamino-1-azanaphthalene
• CAS NO: 42143-23-7
• Molecular Formula: C₉H₉N₃
• Molecular Weight: 159.19
• Mol File: 42143-23-7.mol
• Article Data: 14

Chemical Properties

• Appearance: /
• Solubility: Methanol
• Sensitive: Air Sensitive
• CAS DataBase Reference: QUINOLINE-5,6-DIAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: QUINOLINE-5,6-DIAMINE(42143-23-7)
• EPA Substance Registry System: QUINOLINE-5,6-DIAMINE(42143-23-7)

Safety Data

• Hazard Codes: T
• Hazardous Substances Data: 42143-23-7(Hazardous Substances Data)

Usage

Description

QUINOLINE-5,6-DIAMINE is an organic compound that serves as an intermediate in the synthesis of various chemical compounds. It is characterized by the presence of a quinoline ring with two amine groups attached at the 5th and 6th positions.

Uses

Used in Pharmaceutical Industry:
QUINOLINE-5,6-DIAMINE is used as an intermediate in the synthesis of 2-Aminoimidazo[4,5-f]quinoline (A611680), a metabolite of the carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) (A616500). This application is crucial for the development of pharmaceuticals and understanding the metabolic pathways of carcinogenic compounds.

Upstream product

• 42606-37-1 6-amino-5-nitroquinoline 
• 41554-67-0 5-p-tolylazo-[6]quinolylamine 
• 580-15-4 6-aminoquinoline 
• 100-01-6 4-nitro-aniline 
• 613-50-3 6-nitroquinoline 
• 7647-01-0 hydrogenchloride 
• 35975-00-9 5-amino-6-nitroquinoline 
• 7731-55-7 5-phenylazo-[6]quinolylamine 

Downstream Products

• 233-55-6 imidazo<4,5-f>quinoline 
• 93201-85-5 2-methyl-1(3)H-imidazo[4,5-f]quinoline 
• 93201-86-6 2-ethyl-1(3)H-imidazo[4,5-f]quinoline 
• 87967-75-7 2,3-diphenyl-pyrido[3,2-f]quinoxaline 
• 93201-90-2 2-(2-Methylphenyl)-1H-imidazo<4,5-f>quinoline 
• 93201-89-9 2-Phenylmethyl-1H-imidazo<4,5-f>quinoline 
• 233-55-6 imidazo<4,5-f>quinoline 
• 93201-95-7 2-(2,4-Dichlorophenyl)-1H-imidazo<4,5-f>quinoline 
• 93201-91-3 2-(4-Methylphenyl)-1H-imidazo<4,5-f>quinoline 
• 100672-25-1 3-(4-Methyl-benzyl)-2-p-tolyl-3H-imidazo[4,5-f]quinoline 
• 100672-33-1 N⁶-[1-p-Tolyl-meth-(E)-ylidene]-quinoline-5,6-diamine 
• 93201-94-6 2-(4-Chlorophenyl)-1H-imidazo<4,5-f>quinoline 
• 100672-27-3 3-(4-Chloro-benzyl)-2-(4-chloro-phenyl)-3H-imidazo[4,5-f]quinoline 
• 93201-93-5 2-(2-Chlorophenyl)-1H-imidazo<4,5-f>quinoline 

Relevant articles and documents

-

-

FUSED TRICYCLIC SILYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

no abstract published

FUSED TRICYCLIC COMPOUNDS AND DERIVATIVES THEREOF USEFUL FOR THE TREATMENT OF VIRAL DISEASES

The present invention relates to novel fused tricyclic compounds, compositions comprising at least one fused tricyclic compound, and methods of using fused tricyclic compounds for treating or preventing a viral infection or a virus-related disorder in a patient.

HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF

Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes